Salvage Cryotherapy in Recurrent Prostate Cancer
Public ClinicalTrials.gov record NCT00824928. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To provide a systemic, uniform and user-friendly tool for collection of data on prostate cancer salvage cryotherapy in a multicenter setting. The goal is to learn more about the short and long term efficacy and safety of this procedure. Ultimately the data analysis will serve as a robust guidance instrument for improving upon the utilization of this procedure for the treatment of patients with recurrent (LRD) prostate cancer.
Study identification
- NCT ID
- NCT00824928
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years to 80 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2006
- Primary completion
- May 31, 2012
- Completion
- Nov 30, 2012
- Last update posted
- May 26, 2015
2007 – 2012
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Loma Linda University | Loma Linda | California | 92354 | — |
| Kaiser Permanente | Sacremento | California | 95825 | — |
| Prostate Institute of America | Ventura | California | 93003 | — |
| University of Colorado at Denver and Health Sciences Center | Aurora | Colorado | 80045 | — |
| Lakeland Regional Cancer Center | Lakeland | Florida | 33804 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Midwest Urology/RMD Clinical Research | Melrose Park | Illinois | 60160 | — |
| Indiana University Melvin and Bren Simon Cancer Center | Indianapolis | Indiana | 46202-5289 | — |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201-1379 | — |
| Methodist Hospital | Brooklyn | New York | 11215 | — |
| Nelson Stone (private practice) | New York | New York | 10021 | — |
| Riverside Urology, Inc. | Columbus | Ohio | 43214 | — |
| Rhode Island Hospital/Warren Alpert Medical School of Brown University | Providence | Rhode Island | 02904 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29572 | — |
| University of Tennessee Cancer Institute - Memphis | Memphis | Tennessee | 38104 | — |
| Urology Associates of North Texas | Arlington | Texas | 76012 | — |
| Urology of Virginia, Sentara Medical Group | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Recurrent Prostate Cancer trials
Other public records listing Recurrent Prostate Cancer. Sorted by last update posted; newest first. Not a recommendation.
- NCT07686380: IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy Not yet recruiting
- NCT07593079: Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer Not yet recruiting
- NCT03067051: Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System Recruiting
- NCT06378866: Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial Recruiting
- NCT04787744: Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer Recruiting
- NCT06096870: Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00824928, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 26, 2015 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00824928 live on ClinicalTrials.gov.